Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASSION study of subcutaneous versus intravenous Berinert P in hereditary angioedema
2008-000654-12Phase 3Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of c1-esterase inhibitor in hereditary angioedema (HAE) (2 arms), sponsored by Goethe University Frankfurt. Primary endpoint: Pharmacokinetics of Berinert P after subcutaneous and intravenous administration. Started Jun 2008; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on 2008-000654-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000654-12.